| 000 | 01313 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511145528.0 | ||
| 264 | 0 | _c19790126 | |
| 008 | 197901s 0 0 eng d | ||
| 022 | _a0007-1447 | ||
| 024 | 7 |
_a10.1136/bmj.2.6144.1048 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHomeida, M | |
| 245 | 0 | 0 |
_aDecreased first-pass metabolism of labetalol in chronic liver disease. _h[electronic resource] |
| 260 |
_bBritish medical journal _cOct 1978 |
||
| 300 |
_a1048-50 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 |
_aEthanolamines _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLabetalol _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver Diseases _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSerum Albumin _xanalysis |
| 700 | 1 | _aJackson, L | |
| 700 | 1 | _aRoberts, C J | |
| 773 | 0 |
_tBritish medical journal _gvol. 2 _gno. 6144 _gp. 1048-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.2.6144.1048 _zAvailable from publisher's website |
| 999 |
_c729567 _d729567 |
||